ARTICLE | Company News
MannKind, Receptor Life Sciences deal
February 8, 2016 8:00 AM UTC
MannKind granted newco Receptor Life Sciences a license to formulation and delivery technology to develop multiple inhaled products to treat chronic pain, neurologic diseases and inflammatory disorder...